| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4216013 | Revue des Maladies Respiratoires Actualités | 2013 | 6 Pages |
Abstract
Because of a reduction in the proportion of SCLC, the number of trials addressing SCLC is decreasing. However, there are still many unanswered questions and better survival results are needed. Efforts for molecular subtyping of SCLC are ongoing, with the parallel search for therapies targeting the identified biomarkers. © 2013 SPLF. Published by Elsevier Masson SAS. All rights reserved.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Pulmonary and Respiratory Medicine
Authors
D. Templement, V. Westeel,